Med Oral Patol Oral Cir Bucal:儿童口腔溃疡?那试试光生物调控疗法吧

2020-12-05 MedSci原创 MedSci原创

近日,一项随机对照研究评价了光生物调控疗法(PBMT)治疗儿童轻微复发性口腔溃疡(MiRAS)的效果,从疼痛缓解、病灶缩小及家长对治疗的满意度等方面进行评价。研究结果已在线发表于Med Oral Pa

近日,一项随机对照研究评价了光生物调控疗法(PBMT)治疗儿童轻微复发性口腔溃疡(MiRAS)的效果,从疼痛缓解、病灶缩小及家长对治疗的满意度等方面进行评价。研究结果已在线发表于Med Oral Patol Oral Cir Bucal。

研究纳入了60名临床诊断为MiRAS的儿童,将其随机分为两组:A组接受激光治疗,B组接受假治疗(安慰剂)。在第1天(T0)进行激光治疗(二极管激光,λ:645nm),连续3天在第4天(T1)、第7天(T2)和第10天(T3)对患者进行评估。通过牙周探针测量溃疡直径长度(mm)来评估病变大小;通过视觉模拟量表(VAS)评估疼痛;通过问卷调查评估家长满意度。

 

结果显示,两组之间的溃疡直径减少的幅度在T1和T2时有差异(P<0.05)。T1时两组疼痛减轻情况差异有统计学意义(P<0.05)。两组家长对手术的接受程度和对需要多次预约的不适感,没有发现统计学上的显著差异。

综上所述,该研究结果表明,PBMT可有效治疗儿童MiRAS,得到了儿童父母的认可。

 

原始出处:

 

E Bardellini, F Veneri, et al., Photobiomodulation therapy for the management of recurrent aphthous stomatitis in children: clinical effectiveness and parental satisfaction. Med Oral Patol Oral Cir Bucal. 2020 Jul 1;25(4):e549-e553. doi: 10.4317/medoral.23573.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2020670, encodeId=203020206e020, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Feb 22 09:03:41 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955857, encodeId=f15f95585e08, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=380b5475551, createdName=ms9000001013043154, createdTime=Sun Apr 11 11:06:22 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610817, encodeId=828e161081e47, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 06 15:03:41 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-02-22 小几洁
  2. [GetPortalCommentsPageByObjectIdResponse(id=2020670, encodeId=203020206e020, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Feb 22 09:03:41 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955857, encodeId=f15f95585e08, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=380b5475551, createdName=ms9000001013043154, createdTime=Sun Apr 11 11:06:22 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610817, encodeId=828e161081e47, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 06 15:03:41 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-04-11 ms9000001013043154

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2020670, encodeId=203020206e020, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Feb 22 09:03:41 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955857, encodeId=f15f95585e08, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=380b5475551, createdName=ms9000001013043154, createdTime=Sun Apr 11 11:06:22 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610817, encodeId=828e161081e47, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 06 15:03:41 CST 2020, time=2020-12-06, status=1, ipAttribution=)]

相关资讯

J Oral Pathol Med:沙利度胺可有效延长复发性口腔溃疡的复发间隔

复发性口腔溃疡(RAU)是最常见的口腔黏膜疾病。部分患者的口腔溃疡几乎连续不断,影响生活质量。近日,一项随机对照临床试验观察了沙利度胺对连续性RAU复发间隔的疗效和安全性,发现沙利度胺具有延长连续RA